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Education and debate
Women doctors and their careers: what now?
Isobel Allen
Outmoded career structures and attitudes mean that the UK risks losing out on the valuable
contribution women doctors can make, especially in the second half of their careers
Many people in the medical profession still view
women doctors with scepticism despite their increas-
ing numbers. It is nearly 20 years since I was commis-
sioned by the Department of Health to help them
assess the implications of the fact that women would
soon account for half of medical graduates.1 That
research and its follow-up2 found that both men and
women experienced similar problems and constraints
in their careers, suffering from what they regarded as a
rigid and conservative career structure. They over-
whelmingly supported the provision of more flexible
working patterns so that all doctors could lead a
normal life. How far have women doctors progressed
and what do they feel about the profession?
Change in culture
In 1986, many trainees had to work 120 hours a week
and move to different locations every few months.
Women were asked the most outrageous questions at
interviews, the old boy network and behind the scenes
telephone calls were dominant factors in the selection
process, and women who wanted to reduce their hours
to spend time with their children were not regarded as
proper doctors. Things have changed in medicine, but
perhaps not as fast as in the outside world. Powerful
and influential doctors continue to express fears that
the increasing proportion of women in medicine will
lead to a loss of power and influence and professional
status.3 4 But even if their fears were well founded, the
progress of women in medicine is less than many
people imagine.
Entry to medical school
Women are indeed accounting for a larger proportion
of medical graduates. All through the 1960s women
accounted for about 25% of those entering medical
school. By 1975 the proportion was 35%, rising to 46%
by 1985. In the early 1990s the proportion was around
50% but has since increased each year and is now 61%.5
But just because the proportion of women has
increased over the past few years, it does not neces-
sarily mean that it will go on increasing. We should be
careful before saying that on present trends women
doctors will outnumber men doctors by 2012.6 In nei-
ther hospital medicine nor general practice have
women reached even 40% of the medical workforce.
Hospital medicine
Women accounted for 23% of all grades in hospital
medicine in 1983, rising to 35% in 2003, hardly
swamping the medical workforce (fig 1).7 8 The propor-
tion of women consultants doubled from 12% in 1983
to 24% in 2003 and reached 25% in 2004. Women
account for 39% of specialist registrars (the consultants
of tomorrow) and for 44% of senior house officers. It is
only among preregistration house officers that women
are now in the majority, but still only just over 50%.
One of the reasons for the relatively low represen-
tation of women in postgraduate training grades is
that as many as 42% of senior house officers and 38%
of specialist registrars qualified outside the UK, and
most of these are men.8 Traditionally, most overseas
qualified trainees return to their home countries when
they complete their training and do not take
consultant posts. If we look at UK qualifiers, women
account for 50% of senior house officers and 44% of
specialist registrars.
The specialties with the largest proportions of
women consultants in 1983 were psychiatry, pathology,
and paediatrics (fig 2). Today paediatrics is now well in
the lead with 40% women consultants. It is interesting
that paediatrics with its on-call and out of hours
commitment—things that women are supposed to
Further data are on bmj.com
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shun—is the leading specialty. The number of women
consultants has also increased greatly in acute special-
ties like obstetrics and gynaecology and accident and
emergency. Surgery, however, remains a male preserve,
with only 7% of consultants being female in 2003.7 8
Around 30% of women consultants now work less than
full time.8 Women account for a higher proportion of
specialist registrars, but the overall pattern is similar to
that for consultants (see bmj.com).
Women in general practice
The proportion of women working in general practice
has doubled from 19% in 1983 to 38% (see bmj.com).
The proportion of women principals has more than
doubled from 17% to 35%, but the biggest increase is
among general practice registrars: from 37% to 60%.9 10
Between 1993 and 2003 the proportion of male
principals working full time remained over 90% but
the proportion of women fell sharply from 73% to
53%.9 10 If only just over half of women principals are
working full time, it is unsurprising that we urgently
need to increase numbers entering general practice.
These figures reflect the age profile of women in gen-
eral practice, with high proportions of younger women
with child care responsibilities. These women may
increase their hours when their children are older.
Views of women doctors
I recently conducted a series of five focus groups in a
London hospital with women consultants and special-
ist registrars in their late 20s and 30s. I asked many of
the questions asked in my earlier research, with
particular reference to the work-life balance. I focus
here on the views of consultants. The women came
from amixture of specialties and all had small children.
Some had done flexible training; some were working
full time and others part time. What were the biggest
constraints on their careers and what stresses did they
experience?
Stress at work has been consistently related to lack
of control over the working environment.11 But it was
striking how these women consultants felt that they
were actually “in control,” “calmer” at work than at
home. The things that male consultants found particu-
larly stressful—perceived loss of consultant autonomy,
loss of control over their work environment, concern
about targets, conflicts with managers, poor support
services, and inefficient back-up systems12—paled into
insignificance for the women. “I think you just factor
that in as a normal background source of irritation,”
one commented.
These women consultants stressed the importance
of time management in their lives. All of them consid-
ered proximity to the workplace to be crucial. Certainly
the stability of a fixed job in one place as a consultant
and the removal of the geographical mobility required
of most specialist registrars was a great relief.
The importance of role models or mentors for
women doctors cannot be underestimated. Both
consultants and specialist registrars spoke of the
advantage of having people in the department who
shared the stresses of juggling work and family, not
only other women consultants. An anaesthetist spoke
of her department being “Run by people who have
other lives. It’s not just the surgeons and the anaesthe-
tists, it’s the theatre staff, ward staff. It’s a whole depart-
ment of people saying the operating session has to
stop at half past five.”
Those who had done flexible training said they had
been regarded as very desirable, not only because they
were supernumerary but because they came with fund-
ing attached. But times (and funding) had changed,
and they thought that it was much more difficult now
for potential flexible trainees.
The women thought it better to start full time as a
consultant and then negotiate to less than full time.
They often dropped just one or two sessions, and they
regretted the loss of time for developing services that
resulted. Women registrars and consultants still had
problems in some male dominated specialties.
One consultant had considered an academic career
but had abandoned the idea. She had done a PhD at a
prestigious teaching hospital and could have gone on
to a senior lectureship, but had settled for a consultant
post elsewhere: “I decided I would not be able to juggle
everything—to be a good clinician, plus do the
research, plus have a social life and a family life. I
couldn’t do a senior lecturer job part time. I’d get
kicked out.”
The problem of recruitment to academic medicine,
which has been highlighted by the chief medical






































































































































Fig 2 Proportion of female consultants by specialty
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women’s needs can be accommodated in more flexible
career pathways.14 Attention also needs to be paid to
the particular importance of mentors and role models
for women in academic medicine.13 15
The consultants emphasised that women may have
different career paths from men. This M shaped distri-
bution of women’s careers has been recognised for a
long time: the peak in the early years, the dip in the
middle, and then the potential for a peak in the later
years. My earlier research showed clearly that women
doctors did not drop out after childbirth, as many
people had thought, but continued working, often part
time in general practice or community health. There
are far more opportunities for women now and their
potential contribution in the second half of their
careers should be fully exploited.
Adapting to change
The profile of the medical profession is changing—not
only with increasing proportions of women doctors
but also with increasing proportions of UK qualifiers
from ethnic minorities. The days of the white male
dominated medical profession are numbered. In 2003,
among UK qualified doctors, white men accounted for
68% of consultants but only 33% of senior house offic-
ers and 29% of house officers.8 In 2002, white men
accounted for 26% of entrants to UKmedical schools.16
But does this matter? Great care should be taken
before attributing any potential loss of professional
status to the changing profile of the medical
profession.
We need to take a fresh look at the ingredients of
professional status. I don’t believe that patients value
women doctors any less than men doctors. Much more
damage is likely to have been done to the status of the
medical profession by costly public inquiries into pro-
fessional misdemeanours, mostly resulting from
actions by white male doctors, than by the failure of
women doctors to flock into committees.
It is time to reconsider some of the entrenched val-
ues and attitudes that reinforce the traditional pecking
order in medicine and remain a source of implicit dis-
crimination against women. Should certain specialties
be more highly regarded than others and remain
largely male preserves? Why are all consultants
expected to take on so many different duties,
particularly if they want clinical excellence awards? Are
there no measures of quality other than long hours,
committee membership, and research papers?
Some progress has been made. The profession has
realised that long hours and lengthy, unstructured
training periods do not necessarily ensure a well
equipped and well balanced workforce. But perhaps
the most important recent change to benefit women
doctors—the reduction in hours—has been imposed
from outside the profession with the implementation
of the European working time directive. There has
been some belated recognition that the straight full
time career path so engrained in the mindset of the
medical hierarchy could be open to change. But suspi-
cion remains of those who have more unconventional
career paths or who have not reached a certain grade
by a certain age. Let us hope that the government’s
plans for reform of postgraduate training will allow
more flexibility.17
It is pointless to hanker after some golden age in
which medical careers and working practices were
organised in such a way that nobody who wanted to
lead a “normal” life, whether male or female, could
hope to reach the top of the profession. It was not a
golden age and will never return. The most important
thing for the medical profession to concentrate on now
is how best to use the resources it has and will have in
the foreseeable future. It should be a matter of great
pride that so many brilliant young women are
choosing to enhance the profession, and every effort
should be made to throw out old fashioned practices
and attitudes that inhibit the contribution they can
make both in the early and later stages of their careers.
Contributors and sources: IA has conducted several research
projects on doctors and their careers over the past 20 years,
mostly commissioned and funded by the Department of Health.
This paper is based on a longer paper presented to the annual
conference of the Medical Women’s Federation in November
2004.
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Postgraduate training grades
Postgraduate training is designed to prepare doctors
to become consultants or principals in general
practice. The traditional training pathway is as set out
below but is changing:
Pre-registration house officer—the first year of
postgraduate training, leading to full registration with
the General Medical Council.
Senior house officer— the next two years or more of
general professional and basic specialist training
Specialist registrar—Higher training in a specialty,
usually lasting 4-6 years, after which the doctor is
eligible to apply for consultant posts
GP registrar—Final year of training for general practice,
completing the three year vocational training
Staff grades and associate specialists—Doctors working at
subconsultant level who are not currently in training
Summary points
The medical profession has been slow to adapt to
the fact that women have accounted for over half
of medical students for over 10 years.
Women still account for only just over a third of
hospital doctors and general practitioners
Young women doctors find achieving a work-life
balance stressful
Women doctors have much to offer in the second
half of their careers and should not be prevented
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Open label extension studies: research or marketing?
G J Taylor, P Wainwright
Open label extension studies allow continued prescribing of unlicensed drugs after a randomised
trial, but it is unclear whether patients or drug companies are benefiting the most
Properly designed and conducted open label exten-
sion studies can provide rigorous information on long
term safety and tolerability of potential new drugs. This
in turn can benefit the licensing application for the
drug by providing longer term data that would
otherwise not be available until after the licence was
approved. Nevertheless, the conduct of such studies
raises several ethical and scientific concerns.1 2 As with
any research method, there are good and bad
examples. However, open label extension studies seem
particularly prone to the pressures of marketing over
good research methods and research ethics. We revisit
some of these issues and argue that we need to change
our approach to the ethical review of such studies.
Open label extension studies
Open label extension studies typically follow a double
blind randomised placebo controlled trial of a new
drug. At the end of the double blind phase, participants
are invited to enrol in an extension study. The study
will normally be longer than the randomised trial (two
years is not uncommon but they often continue until
the drug is licensed). All participants in the extension
study are given the study drug, and both they and the
investigators know this. The objective is primarily to
gather information about safety and tolerability of the
new drug in long term, day to day use.
Use of open label studies after phase III trials is
relatively common. In 2004, the multicentre research
ethics committee for Wales reviewed three open label
extension studies compared with 19 phase III studies
of new drugs, a ratio of just over 6:1. However, a recent
Medline search for studies between 2000 and 2004,
produced only 86 open label studies but over 2000
phase III studies, a ratio of 23:1. This suggests that
many open label studies are never published.
Issues of consent
The way that open label extension studies recruit raises
several questions about informed consent. Participants
are invited to join the extension study as soon as their
involvement in the randomised controlled phase III
study is finished. They do not know whether they have
been taking active or placebo treatment, and investiga-
tors will not normally unblind the study at this point.
Participants will thus base their decision on their previ-
ous study experience. Given that participants in either
arm of the trial may have had positive or negative out-
comes, their experience during the trial and their per-
ception of the efficacy of the treatment they have
received cannot be a sound basis on which to make
such a judgment. In addition, as the results of the phase
III study are unavailable, participants will be receiving a
drug without the evidence that the treatment is any
better than the standard treatment; it may potentially
be worse.
The clinical picture of some participants may also
have changed during the phase III trial. Participants
may no longer meet the inclusion criteria or may no
longer require treatment. At the conclusion of a trial
participants are normally reviewed by their doctor.
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